Trial Profile
Clinical study with subsequent subcutaneous administration of GEN0101 in the patients enrolled in the Phase 1 dose-escalation, safety / tolerability and preliminary efficacy study of intratumoral and subcutaneous administration of GEN0101 (GEN0101-JM003).
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 May 2017
Price :
$35
*